Cargando…

Prostate Cancer Drug Therapy: What Have Clinicians Missed During the COVID-19 Pandemic

Due to the COVID-19 pandemic, major congresses and many teaching opportunities as well as the usual visits from medical advisors of pharmaceutical firms have been postponed and canceled. The major trials of prostate cancer in the last 5 years in each state are shortly discussed providing a panoramic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rahnama’i, M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380218/ https://www.ncbi.nlm.nih.gov/pubmed/35950609 http://dx.doi.org/10.1177/15579883221115593

Ejemplares similares

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
por: Vanneste, Ben G. L., et al.
Publicado: (2016)

Neuromodulation for functional bladder disorders in patients with multiple sclerosis
por: Rahnama’i, Mohammad Sajjad
Publicado: (2019)

The Scientific Value of Abstracts on Prostate Cancer Presented at the European Association of Urology Congresses
por: Ataei, Jasmin, et al.
Publicado: (2021)

Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2021)

Missing emergency drugs in ICU - A clinician's nightmare!
por: Williams, Aparna, et al.
Publicado: (2011)

Overcoming Clinician Technophobia: What We Learned from Our Mass Exposure to Telehealth During the COVID-19 Pandemic
por: Sherrill, Andrew M., et al.
Publicado: (2022)

COVID-19 pandemic. What have we learned?()
por: Calvo, Cristina, et al.
Publicado: (2021)

The COVID-19 pandemic — what have urologists learned?
por: Ebner, Benedikt, et al.
Publicado: (2022)

Alcohol consumption during COVID-19 pandemic: What have we learnt so far?
por: Nogueira, V., et al.
Publicado: (2021)

What are the drugs having potential against COVID-19?
por: Kucukoglu, Kaan, et al.
Publicado: (2020)

Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?
por: Agosto, Caterina, et al.
Publicado: (2021)

Current Management of Post-radical Prostatectomy Urinary Incontinence
por: Rahnama'i, Mohammad S., et al.
Publicado: (2021)

Essential ICU drug shortages for COVID-19: what can frontline clinicians do?
por: Siow, Wen Ting, et al.
Publicado: (2020)

COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?
por: Freudenberg, Lutz S., et al.
Publicado: (2022)

Otolaryngology During the COVID-19 Pandemic: What We Have Learned in Year One
por: Chandrasekhar, Sujana S.
Publicado: (2020)

Complementary and alternative medicine during COVID-19 pandemic: What we have done
por: Ling, Chang-quan
Publicado: (2022)

Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
por: Al-Musa, Amer, et al.
Publicado: (2022)

Newly detected diabetes during the COVID-19 pandemic: what have we learnt?
por: Hirani, Dhruti, et al.
Publicado: (2023)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Retinal Glaucoma Public Datasets: What Do We Have and What Is Missing?
por: Camara, José, et al.
Publicado: (2022)

Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

Dry eye disease revisited: What have we missed?
por: Sun, Chi-Chin
Publicado: (2019)

Medical education during the COVID-19 pandemic: What students missed and what they did not. A questionnaire-based cross-sectional study
por: Manzini, Giulia, et al.
Publicado: (2023)

Clinician's Perception of Practice Changes for Stroke During the COVID-19 Pandemic
por: Kamdar, Hera A., et al.
Publicado: (2020)

Just the Facts: Protecting frontline clinicians during the COVID-19 pandemic
por: Atkinson, Paul, et al.
Publicado: (2020)

Clinician burnout during the COVID-19 pandemic before vaccine administration
por: Bakken, Brianne K., et al.
Publicado: (2021)

Clinician-researcher’s perspectives on clinical research during the COVID19 pandemic
por: Silverberg, Sarah L., et al.
Publicado: (2020)

Missing Diagnoses during the COVID-19 Pandemic: A Year in Review
por: Pifarré i Arolas, Héctor, et al.
Publicado: (2021)

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis
por: Rahnama’i, Mohammad-Sajjad, et al.
Publicado: (2023)

What have we learned in the 3 years of the COVID-19 pandemic?
por: Maisch, Bernhard, et al.
Publicado: (2023)

COVID-19 and diabetes: What does the clinician need to know?
por: Papadokostaki, Eleni, et al.
Publicado: (2020)

COVID-19: What Should Clinicians and Scientists Do and When?
por: Corley, Douglas A., et al.
Publicado: (2020)

11. Missed Vaccine Opportunities During the COVID-19 Pandemic
por: Shallal, Anita, et al.
Publicado: (2020)

Missed routine cardiovascular treatments during the COVID-19 pandemic
Publicado: (2023)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
por: Honore, Patrick M., et al.
Publicado: (2020)

Lower urinary tract signs and symptoms in patients with COVID-19
por: Marand, Aida Javan Balegh, et al.
Publicado: (2021)

The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function
por: Zare, Aryo, et al.
Publicado: (2018)

Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
por: Giannis, Dimitrios, et al.
Publicado: (2022)

Pandemic preparedness planning in peacetime: what is missing?
por: Osterhaus, Ab, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hsklahh1td4cbbgu17445lo7r